How much funding has Denali Therapeutics raised?

Denali Therapeutics has raised $1.3B in total funding, most recently a Venture Round.

Who are Denali Therapeutics's investors?

Denali Therapeutics's investors include Royalty Pharma, Baillie Gifford, Redmile Group, Private Investors, Flagship Pioneering, GV.

When was Denali Therapeutics founded?

Denali Therapeutics was founded in 2015.

Where is Denali Therapeutics headquartered?

Denali Therapeutics is headquartered in South San Francisco, California, United States.

What industry is Denali Therapeutics in?

Denali Therapeutics operates in Biotech, Healthcare.

How many employees does Denali Therapeutics have?

Denali Therapeutics has 201-500 employees.

Denali Therapeutics

IPO

Transforming Life

Public · South San Francisco, United States · Founded 2015 · $1.3B raised

Biotech

Healthcare

Headquarters: South San Francisco, California
Employees: 201–500
Founded: 2015
Business Model: B2B
Website: denalitherapeutics.com

Total Funding: $1.3B
Last Round: $200.0M Venture RoundDec 2025
Rounds: 5
Type: Public

About

Denali Therapeutics is a clinical-stage biotechnology company that invented the TransportVehicle™ platform, enabling biotherapeutics to cross the blood-brain barrier and treat neurodegenerative, lysosomal storage, and other serious diseases. With a clinically validated delivery platform, Denali is advancing a broad pipeline of investigational medicines in collaboration with partners including Biogen and Takeda.

Summary

Denali Therapeutics is a Biotech company based in South San Francisco, United States, founded in 2015. It has raised $1.3B in total across 5 rounds, most recently a $200.0M Venture Round round in Dec 2025. Investors include Royalty Pharma, Baillie Gifford and Redmile Group.

LinkedIn X (Twitter)